Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Testing A Combination Of Vaccines For Cancer Prevention In Lynch Syndrome
Glossary on
off
Printer Friendly Page Testing A Combination Of Vaccines For Cancer Prevention In Lynch Syndrome

Testing A Combination Of Vaccines For Cancer Prevention In Lynch Syndrome

Clinicaltrials.gov identifier:
NCT05419011

Prevention
Testing A Combination Of Vaccines For Cancer Prevention In Lynch Syndrome

Study Contact Information:

For more information, please contact [email protected]


Lynch Syndrome Vaccine Study

About the Study

(LS) increases the risk of colon cancer and other cancers, including cancer of the uterus, ovaries, small bowel, stomach, pancreas, urinary tract, skin, and brain.

This study is being done to assess the safety and effectiveness of a series of vaccines (Tri-Ad5), together with another drug (N-803) that magnifies the body’s response to vaccines, to see if there is an effect on the risk of developing colon and other cancers in LS patients.

For more Information, visit https://bit.ly/ihavelynch

What the Study Involves

If you consent and are eligible to join this trial, you will attend a total of 8 study appointments. During these visits you will receive a series of injections (3-4 injections four times over a one-year period) and undergo yearly colonoscopies as part of routine care. You can also expect physical exams, blood draws, review of your medical history, and completion of questionnaires and a vaccine report card to report any injection side effects.

Study Locations

Arizona

  • Tucson, AZ
    University of Arizona Cancer Center - Prevention Research Clinic
    Lead Research, Aaron Scot: 
    Contact: Aaron J. Scott    520-626-6453 [email protected]

Illinois

  • Chicago, IL
    Northwestern University
    Lead Researcher: Mohammad A. Abbass
    Contact: Mohammad A. Abbass    312-694-4789    [email protected]

Kansas

  • Kansas City, KS
    University of Kansas Medical Center
    Lead Researcher: Ajay Bansal, MD
    Contact:  913-588-6003    [email protected] 

Massachusetts

  • Boston, MA
    Dana-Farber Cancer Institute
    Lead Researcher: Ramona M. Lim, MD
    Contact: 617-582-7777    [email protected]

Michigan

  • Ann Arbor, MI
    University of Michigan Comprehensive Cancer Center
    Lead Researcher: Elena Stoffel, MD
    Contact: 734-936-0781    [email protected]

Texas

  • Houston, TX
    University of Texas MD Anderson Cancer Center, Houston, TX
    Lead Researcher: Eduardo Vilar-Sanchez, MD, PhD
    Contact: 713-563-4743    [email protected]
This Study is Open To:

People 18 years or older who:

  • Have been diagnosed with and have had abnormal growths in their colon or rectum.
  • Have not had any cancer treatment in the past 6 months.
  • Are not pregnant or planning to get pregnant.
This Study is Not Open To:

People who do not meet the eligibility criteria defined above and those who:

  • Have experienced severe side effects or allergic reations to previous vaccines.
  • Have a blood clotting disorder.
  • Have had organ transplants.
  • Are pregnant or breastfeeding.